TBMED
An Open Innovation test bed for the development of high-risk medical devices
- Description
TBMED aims to support European med-tech companies in global competition by reducing the time-to-market of high-risk medical devices (MD). An Open Innovation test bed for the development of devices of risk classification IIb and higher will provide expert support from an early development stage to the optimised transformation of prototypes into valuable and innovative products.
- Coordinator
Related News
- Programme
- Horizon 2020 & sub-programmes
- Duration
- 56 months (January 2019 - August 2023)
- Project funding
- € 8,480,543.89
- Project partners
- 13
- Technology readiness level
- 4-7